Monday, April 25, 2016

BRIEF-Transition Therapeutics says dosing of first patient in Phase 2 study of drug candidate TT701

* Transition therapeutics announces dosing of first patient

in phase 2 study of drug candidate tt701

Source text for Eikon:

Further company coverage:

(Bengaluru Newsroom: +1-646-223-8780)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)